Skip to main content
. 2021 Sep 27;62(1):117–124. doi: 10.47162/RJME.62.1.11

Figure 14.

Figure 14

Well-differentiated colon adenocarcinoma with intense reaction of tumor cells to p53 immunomarker. Immunolabeling with anti-p53 antibody, ×100